Intrauterine Growth Restriction
Intrauterine Growth Restriction (IUGR), also known as fetal growth restriction, is a condition characterized by poor or stunted growth of a baby in the womb due to various factors such as maternal, fetal, or placental complications, including lack of oxygen and nutrients to the placenta, high altitude, placenta problems, preeclampsia/eclampsia, or multiple pregnancies like twins or triplets. The condition is marked by clinical signs of malnutrition and reduced growth, regardless of the infant's birth weight percentile.
Health Outcomes
- Achieved Adequate Infant Growth
- Adjusted Height-for-Age Z Score
- Healthy Age-Appropriate Growth
- Improved Anthropometric Status
- Improved Apgar Score at 1 Minute
- Improved Birth Weight
- Improved Body Growth
- Improved Child Growth and Development
- Improved Child Neurodevelopment (Adaptive Domain)
- Improved Fetoplacental Circulation
- Improved Growth
- Improved Growth Indices
- Improved Growth Metrics
- Improved Growth Performance
- Improved Growth Rate Standard Deviation Score
- Improved Growth and Economic Traits
- Improved Growth in Children
- Improved Gut Microbiome Establishment
- Improved Head Circumference Gain
- Improved Head Growth
- Improved Height-for-Age Z-Score
- Improved Infant Gut Microbiome Development
- Improved Infant Gut Microbiota Restoration
- Improved Infant Health
- Improved Infant Motor Development
- Improved Neonatal Health Outcomes
- Improved Neurodevelopmental Outcome
- Improved Perinatal Safety
- Improved Physiological Status in Offspring
- Improved Postnatal Development
- Improved Pregnancy Outcome
- Improved Psychomotor Development
- Improved Recumbent Length Gain
- Improved Survival Rate at Weaning
- Improved Uterine Artery Doppler Parameter
- Improved Weight-for-Age Z Score
- Increased CSF3 Output in Placental Trophoblast Cells
- Increased Folate Bioavailability
- Increased Neonatal Death
- Increased Survival Rate at Weaning
- Influence on Infant Weight
- Modified Fetal Brain Metabolism
- No Improvement in Adverse Pregnancy Outcomes
- No Improvement in Growth Performance
- Normal Infant Growth
- Normal Pregnancy Outcomes
- Reduced Birth Weight
- Reduced Fetal Complication
- Reduced Fetal Intrauterine Growth Retardation Rate
- Reduced Fetal Loss
- Reduced Full Feeding Days
- Reduced Gestational Age at Delivery
- Reduced Growth Performance
- Reduced Incidence of Late-Onset Sepsis
- Reduced Intrauterine Fetal Demise
- Reduced Intrauterine Growth Restriction Rate
- Reduced Intrauterine Growth Retardation Risk
- Reduced Low Birthweight
- Reduced Maternal Complication
- Reduced Maternal and Neonatal Composite Outcome
- Reduced Maternal-Fetal Complications
- Reduced NICU Admission
- Reduced NICU Requirement
- Reduced Neonatal Complication
- Reduced Neonatal Death
- Reduced Neonatal Mortality
- Reduced Neonatal Risk
- Reduced Periconceptional Supplementation
- Reduced Perinatal Loss
- Reduced Perinatal Mortality
- Reduced Physical Growth
- Reduced Pre-eclampsia or Pregnancy Loss
- Reduced Preconceptional Supplementation
- Reduced Preeclampsia Development
- Reduced Rate of Preterm Births Under 34 Weeks
- Reduced Risk of Infant Health Problems
- Reduced Risk of Pregnancy Complications
- Reduced Risk of Small-for-Gestational Age
- Reduced Stillbirth
- Reduced Stillbirth or Fetal Death
- Reduced Stunting Prevalence
- Reduced Time to Regain Birth Weight
- Reduced Time to Regain Birthweight
- Reduced Toxoplasma gondii Burden
- Reduced Uterine Activity
- Shortened Second Stage of Labor
- Time to Full Enteral Feeding in Postnatal Age